Kevin has partnered with biopharmaceutical companies for nearly 15 years to implement creative, data-supported solutions to meet their commercial challenges. Kevin’s approach is rooted in a deep understanding of industry trends and major therapeutic areas, with specific focus on immunology, oncology, cardiovascular, and rare diseases. Through his work on business development strategy, portfolio design, and new product planning, he has contributed to billions of dollars of acquisitions, helped companies develop and execute global growth strategies, and supported numerous blockbuster product launches.

Kevin earned a BA from Dartmouth College and a Masters of Public Health from Tufts University. When he isn’t in the office, Kevin can be found playing basketball and tennis, or traveling with his wife and two young sons, camera in hand.